Weekly Rundown: Key Catalysts for Small-Cap Stocks (October 6–10)

From recent disclosures to corporate shifts, we’ve highlighted the top small-cap catalysts to watch. Here’s your weekly preview (October 6-10).

--

Companies Presenting at Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference (October 8–9, 2025):

RGP • ASBP • COCP • CRDF • EHTH • VNCE • TOI

Companies Presenting at the 2025 Cell & Gene Meeting on the Mesa Conference (October 6–8, Phoenix, Arizona):

TNYA • IRD • OCGN • FBLG • LGVN • ERNA

Other Companies with Catalysts This Week:

EPOW • CEO Haiping Hu, senior staff, and subsidiary Alchemistica Incorporated (energy storage battery packs) will attend The Battery Show North America 2025 — the largest battery exhibition in North America — held in Detroit, October 6–9.

BFRG • Director of AI, Machine Learning & Innovation, Juan Felipe Beltrán Lacouture, PhD, will present a live Xtalks webinar, “Clinical Data Analysis with Agents: Reliable Automation with Human Oversight,” on Monday, October 6 at 11:00 a.m. EDT.

GPUS • Plans a special one-time dividend of 20,000,000 shares of Class B Common Stock to all Common and Preferred Stockholders of record as of October 6. Payment date: October 31, 2025.

GORV • Entered a Letter of Intent with Campers Inn Holding Corporation for the potential sale of substantially all assets. The exclusivity period runs through October 6, 2025.

EVAX • Participating in BiotechX Europe in Basel, October 6–8.

SLE • Featured at AdWeekNY’s inaugural Gaming Summit on October 7, exploring gaming’s role in modern media and marketing.

PEPG • Presenting two oral sessions at the 30th Annual World Muscle Society Congress (Vienna, October 7–12), including Phase 1 and Phase 2 trial results for FREEDOM-DM1 and CONNECT1-EDO51.

NMTC • Hosting a virtual roadshow webinar with a corporate update and Q&A on October 7.

GANX • Presenting early Phase 1b data at the International Congress of Parkinson’s Disease and Movement Disorders in Honolulu on October 7.

VNRX • Sponsoring GenomeWeb webinar “Beyond the Genome: Measuring Epigenetic Modifications Across Matrices for Biomarker and Drug Discovery,” on October 8.

STTK • CEO Taylor Schreiber, M.D., Ph.D., to participate in Wedbush UEGW Conference 2025 Rewind panel on October 8.

GRWG • Participating in IgniteIt’s “Cannabis Market Spotlight: California” event in Anaheim on October 8.

BIVI • Hosting an investor webinar at 4:15 p.m. ET on October 8, led by CEO Cuong Do, discussing progress on bezisterim (NE3107) and BIV201.

CCLD • Hosting a live Marketware product demonstration on October 8 at 1:00 p.m. ET, following its acquisition through Medsphere.

CPOP • Approved a strategic investment in the crypto asset XPOP on September 18, 2025; transaction expected to close around October 8, 2025.

TVGN • CIO Mittul Mehta will speak at the Databricks DATA + AI World Tour Startup Forum on October 8.

RVPH • CEO Laxminarayan Bhat, Ph.D., will present and hold investor meetings at the Roth 4th Annual Healthcare Opportunities Conference on October 9 in New York.

ATHE • Presenting Phase 2 data on ATH434 in Multiple System Atrophy at the International Congress of Parkinson’s Disease and Movement Disorders on October 8 in Honolulu.

IMUX • Immunic Therapeutics has multiple upcoming data presentations across major global conferences. At UEGW 2025 (Berlin, October 4–7), the company will present new data on IMU-856, an orally available epigenetic modulator targeting SIRT6, in an oral presentation, publication, and ePoster. At the ISNI 2025 Congress (Chiba, Japan, October 5–8), Immunic’s Head of Research, Evelyn Peelen, Ph.D., will present preclinical findings on IMU-838, its Nurr1 activator, showing signs of neuroprotection. Finally, CEO Daniel Vitt, Ph.D., and CFO Glenn Whaley will participate in the Roth 4th Annual Healthcare Opportunities Conference (New York, October 9), joining a panel on innovation in underserved indications and meeting with investors.

ALUR • Participating in the Roth 4th Annual Healthcare Opportunities Conference on October 9 in New York.

CV • CEO Johnny Wang and Head of Global Sales Doug Atkinson attending Roth Healthcare Opportunities Conference on October 9 in New York.

XAIR • CFO Douglas Larson to participate in Roth Healthcare Opportunities Conference on October 9 in New York.

BDN • Declared a quarterly dividend of $0.08 per share, payable October 23 to holders of record on October 9.

PYPD • Participating in Roth Healthcare Opportunities Conference on October 9.

HITI • Vahan Ajamian to speak at Cantech Letter Conference in Toronto on October 9.

GMGI • Expanse Studios, subsidiary of Golden Matrix Group, attending Global Gaming Expo (G2E) in Las Vegas, October 6–9.

BTCM • Announced rebrand to SOLAI (NYSE: SLAI) to reflect its evolution into an AI-powered blockchain infrastructure company. Extraordinary general meeting scheduled for October 9, 2025, in Akron, OH.

TYGO • Showcasing Tigo GO Optimized Energy Storage System (ESS) and other innovations at Energy 2025 Tradeshow in San Juan, Puerto Rico, October 10.

ADGM • Presenting FULCRUM-VT study results at the 20th Annual International Symposium on Ventricular Arrhythmias in Philadelphia, October 10–11.

TSI • Quarterly distribution of $0.065 per share payable October 10.

OSTX • Announcing 2-year overall survival data from Phase 2b OST-HER2 study on October 10.

IRD • Participating in Fierce Biotech Week and American Academy of Optometry Annual Meeting 2025 (Boston, October 8–9).

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.